Integrative Analysis of Genetic-Ecological Factors Shaping Epimedium Chemical Diversity

Epimedium is commonly used to treat bone injury and kidney disease, with prenylated flavonol glycosides (PFGs) as its active ingredients. It has attracted much attention due to prominent healthcare and therapeutic effects, but faces problems of adulteration with closely related species and confusion about geographical origins. In this study, multiple technical approaches were employed to identify its genetic characteristics and metabolic differences. Based on DNA barcoding, 20 batches of samples were analyzed. The genetic distances of matK, ITS and psbA-trnH within species were all smaller than those between species, and psbA-trnH along with ITS + psbA-trnH proved most effective in distinguishing botanical sources. With Inter-simple sequence repeat (ISSR) technology, 12 highly polymorphic and reproducible primers were selected from 21, and 189 alleles were detected. Epimedium sagittatum showed distinct genetic diversity. Samples with similar genetic distance and geographical location also tended to cluster together. Eight index components were analyzed, and their contents showed significant differences. The total content ranged from 0.50% to 7.09%, and icariin and epimedin C were identified as potential biomarkers. Integrative analysis revealed that the differences in index components were jointly driven by genetic diversity and ecological factors. Additionally, “mean temperature of driest quarter”, “precipitation seasonality”, and “temperature annual range” were identified as key environmental factors. This study provides a reliable experimental basis for the authenticity and quality evaluation of Epimedium.